Valuation: AbbVie Inc.

Capitalization 335B 286B 267B 247B 459B 28,736B 513B 3,194B 1,215B 13,425B 1,257B 1,231B 49,121B P/E ratio 2025 *
26.9x
P/E ratio 2026 * 20.5x
Enterprise value 390B 333B 310B 287B 534B 33,406B 597B 3,713B 1,413B 15,607B 1,462B 1,431B 57,105B EV / Sales 2025 *
6.51x
EV / Sales 2026 * 5.88x
Free-Float
96.39%
Yield 2025 *
3.46%
Yield 2026 * 3.62%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.08%
1 week-0.67%
Current month+2.07%
1 month+0.16%
3 months+5.35%
6 months+8.16%
Current year+6.62%
More quotes
1 week 186.67
Extreme 186.67
193
1 month 181.73
Extreme 181.73
193.59
Current year 164.39
Extreme 164.39
218.66
1 year 163.81
Extreme 163.81
218.66
3 years 130.96
Extreme 130.9601
218.66
5 years 79.11
Extreme 79.1101
218.66
10 years 45.45
Extreme 45.45
218.66
More quotes
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 58 2022-06-22
Chief Tech/Sci/R&D Officer - 2002-12-31
Director TitleAgeSince
Director/Board Member 64 2012-12-31
Director/Board Member 73 2012-12-31
Director/Board Member 67 2012-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.08%-0.67%+12.75%+23.65% 335B
+1.07%+0.75%-15.80%+137.16% 698B
-0.13%-0.01%+5.77%-12.79% 375B
-1.53%+0.35%-54.14%+9.26% 313B
+0.89%-0.04%+6.30%-20.36% 259B
-0.16%-0.89%+0.47%+17.53% 240B
+0.21%-0.27%-13.25%-7.10% 217B
+2.99%+1.74%-33.50%-11.11% 204B
-0.60%-0.78%-6.77%+18.86% 160B
-0.68%+0.41%-8.28%-51.93% 146B
Average +0.16%+0.74%-10.64%+10.32% 294.8B
Weighted average by Cap. +0.26%+0.50%-10.80%+31.33%
See all sector performances

Financials

2025 *2026 *
Net sales 59.86B 51.13B 47.65B 44.07B 82.02B 5,131B 91.69B 570B 217B 2,397B 225B 220B 8,772B 64.72B 55.28B 51.52B 47.65B 88.68B 5,548B 99.14B 617B 235B 2,592B 243B 238B 9,484B
Net income 11.59B 9.9B 9.22B 8.53B 15.88B 993B 17.75B 110B 42.01B 464B 43.47B 42.57B 1,698B 15.37B 13.13B 12.24B 11.32B 21.06B 1,318B 23.55B 146B 55.73B 616B 57.66B 56.47B 2,253B
Net Debt 54.48B 46.54B 43.37B 40.11B 74.65B 4,670B 83.46B 519B 198B 2,182B 204B 200B 7,984B 45.15B 38.57B 35.94B 33.24B 61.87B 3,871B 69.16B 430B 164B 1,808B 169B 166B 6,616B
More financial data * Estimated data
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.4%), Germany (2.6%), Japan (2%), Canada (1.9%), China (1.6%), France (1.4%), Spain (1%), the United Kingdom (0.9%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and other (9.7%).
Employees
55,000
Calendar
More about the company
Date Price Change Volume
25-07-09 190.25 $ +0.25% 2,265,659
25-07-08 189.77 $ +1.14% 7,106,896
25-07-07 187.63 $ -0.87% 11,049,426
25-07-03 189.28 $ -0.77% 3,706,217
25-07-02 190.75 $ +0.40% 4,658,511

Delayed Quote Nyse, July 09, 2025 at 02:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
189.77USD
Average target price
209.12USD
Spread / Average Target
+10.20%
Consensus

Quarterly revenue - Rate of surprise